Top Stories
The company's Alturion system has secured FDA 510(k) clearance and CE mark certification to help improve efficiency in busy care settings.
The series B financing supports the Chinese company's oral GLP-1 candidate and expansion of its AI drug-discovery engine.
OpenDDE gives researchers a public tool for modelling how antibodies, proteins and small molecules interact.
The deal follows a June scale-up for GenoSphere, which Helix said has doubled in size each of the past two years and is tracking towards one million linked clinico-genomic records within 18 months.
The analysis is the largest to show that post-surgical MRD status may help identify which patients with resected colorectal liver metastases benefit from adjuvant chemotherapy.
Conference News
Heartflow Plaque StagingTM, the only staging tool based on total plaque volume*, is now included with every Heartflow Plaque AnalysisData from over 36,000 patients validate the accuracy, reproducibili...
Analyses across Kisunla (donanemab-azbt) trials providing further insights into the benefit-risk profile from long-term extension dataNew data compares the diagnostic performance of P-tau217 blood tes...
BOSTON, July 8, 2026 /PRNewswire/ -- Linus Health, an AI-driven brain health company focused on early detection and proactive intervention, will share three poster presentations at the Alzheimer's Ass...
Three of six SCCT 2026 Young Investigator Award-nominated abstracts utilize Caristo's technologies, including—for the first time—an application of FAI-Score on non-contrast cardiac CTOXFORD, England a...
Showcasing AI-powered brain imaging analysis solutions, including Neurophet AQUA and Neurophet SCALE PETEngaging in partnering meetings with global pharmaceutical companies and CROs to accelerate busi...
